Literature DB >> 21871766

Serum intestinal fatty acid binding protein and phosphate levels in the diagnosis of acute intestinal ischemia: an experimental study in rabbits.

Zerrin Defne Dundar1, Basar Cander, Mehmet Gul, Keziban Ucar Karabulut, Sedat Kocak, Sadik Girisgin, Idris Mehmetoglu, Hatice Toy.   

Abstract

BACKGROUND: Acute intestinal ischemia is a serious clinical disorder with mesenteric infarction, which has high mortality. It is important to establish a biochemical marker for the early diagnosis of acute intestinal ischemia.
OBJECTIVES: The aim of this experimental study was to assess the changes in the serum levels of intestinal fatty acid binding protein (IFABP) and phosphate by time using the acute intestinal ischemia model in rabbits.
METHODS: In this study, 21 New Zealand rabbits were randomly divided into three groups. Blood samples were obtained at 0, 1, 3, and 6 h in the control group. Blood samples were obtained at 0, 1, 3, and 6 h in the sham group after simple laparotomy. Blood samples were obtained at the same hours in the ischemia group after simple laparotomy and ligation of the superior mesenteric artery.
RESULTS: There was no significant difference between the control, the sham, and the ischemia groups in terms of serum IFABP levels at any time (p > 0.05). Serum phosphate levels significantly increased in the ischemia group (p < 0.001). Studies on IFABP have begun emerging in the literature, and there is no standard approach for the technique to measure the IFABP level. No studies on IFABP were found in the literature on rabbits.
CONCLUSION: Based on our results, the role that IFABP levels play in the diagnosis of acute intestinal ischemia is unclear at this time. Serum phosphate levels continued to rise as the duration of ischemia was prolonged. These findings support the suggestion that serum phosphate levels are valuable for the diagnosis of acute intestinal ischemia.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21871766     DOI: 10.1016/j.jemermed.2011.05.051

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

Review 1.  Current status on plasma biomarkers for acute mesenteric ischemia.

Authors:  Stefan Acosta; Torbjörn Nilsson
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Immunomodulating dose of levamisole stimulates innate immune response and prevents intestinal damage in porcine rotavirus diarrhea: a restricted-randomized, single-blinded, and placebo-controlled clinical trial.

Authors:  Gollahalli Eregowda Chethan; Ujjwal Kumar De; Jugal Garkhal; Shubhankar Sircar; Yash Pal Singh Malik; Nihar Ranjan Sahoo; Med Ram Verma
Journal:  Trop Anim Health Prod       Date:  2019-02-21       Impact factor: 1.559

3.  Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis.

Authors:  Wen-He Zheng; Yan Yao; Hua Zhou; Yuan Xu; Hui-Bin Huang
Journal:  Front Med (Lausanne)       Date:  2022-05-17

4.  Temporal relationship of serum markers and tissue damage during acute intestinal ischemia/reperfusion.

Authors:  Francisco Javier Guzmán-de la Garza; Juan Manuel Ibarra-Hernández; Paula Cordero-Pérez; Pablo Villegas-Quintero; Claudia Ivette Villarreal-Ovalle; Liliana Torres-González; Norma Edith Oliva-Sosa; Gabriela Alarcón-Galván; Nancy Esthela Fernández-Garza; Linda Elsa Muñoz-Espinosa; Carlos Rodrigo Cámara-Lemarroy; José Gerardo Carrillo-Arriaga
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.